B.C. medicare challenge: health-care economist says regulations can prevent adverse effects of expanding private financing Trends & Insights 2016: Pharmacists have their sayA sneak peek at results from our exclusive Trends & Insights survey of community pharmacists. Bayer, Versant launch new stem-cell therapy company based in Toronto Clinical Feature: Loperamide misuse Take steps to identify patients at risk, minimize harm and prevent misuse. Press review – December 14, 2016 Bodybuilder becomes body destroyer Doctors warn of bizarre practices such as intramuscular injection of natural oils Canadian Diabetes Association recognizes cardiovascular benefits of liraglutide Revised interim statement includes liraglutide as an option for adults with type 2 diabetes and clinical cardiovascular disease. Ontario health alliance moves to track risk factors for chronic disease Your patient has a lower GI bleed on ASA—Do you resume antiplatelet therapy? Study suggests balance favours resumption, to reduce cardiovascular risk What your patients are reading – week of December 5, 2016 First Previous 192 193 194 195 196 Next Last
